The role of SRC-3 in estrogen-dependent vasoprotection during vascular wall remodeling postinjury

Jianming Xu1

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA. jxu@bcm.tmc.edu

Insights

Estrogen receptors and coactivators are crucial for protecting blood vessels during remodeling. Their interaction influences gene transcription, impacting vascular health.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Estrogen receptors (ERs) are key nuclear receptors regulating gene expression.
  • Coactivators, like the SRC/p160 family, are essential for ER-mediated transcription.
  • Vascular wall remodeling involves complex cellular and molecular changes.

Purpose of the Study:

  • To explore the interaction between estrogen receptors and coactivators.
  • To understand their role in vasoprotection during vascular remodeling.
  • To highlight the significance of this interplay in cardiovascular health.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of molecular mechanisms involving ERs and coactivators.
  • Examination of studies on vascular wall remodeling and vasoprotection.

Main Results:

  • Estrogen receptor and coactivator complexes modulate target gene transcription.
  • This interplay is critical for maintaining vascular integrity.
  • Dysregulation can contribute to vascular pathologies.

Conclusions:

  • The interaction between estrogen receptors and coactivators is vital for vasoprotection.
  • Targeting this pathway may offer therapeutic strategies for vascular diseases.
  • Further research is needed to fully elucidate these mechanisms.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...